HomeCompareARLLF vs JNJ

ARLLF vs JNJ: Dividend Comparison 2026

ARLLF yields 5.13% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ARLLF wins by $56.3K in total portfolio value
10 years
ARLLF
ARLLF
● Live price
5.13%
Share price
$77.56
Annual div
$3.98
5Y div CAGR
26.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$76.3K
Annual income
$16,806.83
Full ARLLF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — ARLLF vs JNJ

📍 ARLLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodARLLFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ARLLF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ARLLF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARLLF
Annual income on $10K today (after 15% tax)
$435.92/yr
After 10yr DRIP, annual income (after tax)
$14,285.81/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, ARLLF beats the other by $13,582.19/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARLLF + JNJ for your $10,000?

ARLLF: 50%JNJ: 50%
100% JNJ50/50100% ARLLF
Portfolio after 10yr
$48.2K
Annual income
$8,817.30/yr
Blended yield
18.30%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ARLLF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
0.8
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARLLF buys
0
JNJ buys
0
No recent congressional trades found for ARLLF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricARLLFJNJ
Forward yield5.13%3.36%
Annual dividend / share$3.98$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR26.9%5.8%
Portfolio after 10y$76.3K$20.0K
Annual income after 10y$16,806.83$827.78
Total dividends collected$49.2K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: ARLLF vs JNJ ($10,000, DRIP)

YearARLLF PortfolioARLLF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,351$650.80$10,676$355.77+$675.00ARLLF
2$13,021$876.09$11,407$389.39+$1.6KARLLF
3$15,125$1,191.96$12,198$426.53+$2.9KARLLF
4$17,826$1,642.00$13,056$467.62+$4.8KARLLF
5$21,369$2,295.11$13,987$513.12+$7.4KARLLF
6$26,127$3,262.95$14,998$563.56+$11.1KARLLF
7$32,688$4,731.59$16,098$619.52+$16.6KARLLF
8$41,997$7,020.64$17,295$681.69+$24.7KARLLF
9$55,634$10,697.51$18,599$750.82+$37.0KARLLF
10$76,335$16,806.83$20,022$827.78+$56.3KARLLF

ARLLF vs JNJ: Complete Analysis 2026

ARLLFStock

Argan SA engages in designing, building, developing, owning, leasing, and managing logistical platforms in France. It is also involved in the development and management of land. The company's real estate property consists of a total area of 806,000 square meters. It serves shippers and logistics companies. The company was founded in 1993 and is based in Neuilly sur Seine, France.

Full ARLLF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this ARLLF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARLLF vs SCHDARLLF vs JEPIARLLF vs OARLLF vs KOARLLF vs MAINARLLF vs ABBVARLLF vs MRKARLLF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.